The main goal is to determine the main differences regarding the early-onset cumulative apoptotic (caspases) and the antiapoptotic (survivin protein) status, amongst patients with septic shock or sepsis compared to patients with non-infectious (traumatic) systemic inflammatory response syndrome (SIRS) or healthy controls. The gene discussed is BIRC5; the disease is systemic inflammatory response syndrome.